Aim immunotech inc. (HEB)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

-9,976

-9,533

-9,966

-10,096

-10,479

-9,827

-10,199

-8,373

-8,151

-8,259

-7,439

-9,049

-8,159

-7,502

-9,466

-10,407

-13,949

-15,230

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustments to reconcile net loss to net cash used in operating activities:
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-18,489

-19,940

-18,657

-17,354

-15,010

-11,163

-10,457

-9,015

0

0

0

Depreciation of property and equipment

714

735

755

792

834

856

867

888

903

948

1,004

1,047

1,080

1,119

1,132

1,059

1,061

941

828

791

678

665

667

653

659

671

678

697

673

643

612

563

502

465

0

0

0

Amortization and abandonment of patent and trademark rights

-

-

-

-

-

-

-

-

-

63

107

131

167

184

208

240

208

249

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization and abandonment of patent and trademark rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

155

122

42

40

33

60

61

165

0

0

0

Redeemable warrants valuation adjustment

-1,373

-1,510

-1,824

-2,073

-1,351

-1,165

-882

-1,625

-1,793

-2,417

-3,935

-2,600

-2,070

-1,677

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of convertible note adjustment

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in convertible debt - refinancing

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Extinguishment of convertible note

-

345

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant modification

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of patent, trademark rights

248

57

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in ROU assets

37

37

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity-based compensation

874

853

827

743

818

929

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock for accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

359

415

518

384

262

134

23

71

0

0

0

Equipment acquired by capital leases

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

62

0

0

0

Unrealized loss on marketable securities

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-637

-1,353

-59

346

198

-566

-603

-585

0

0

0

Redeemable warrants valuation adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-85

865

-3,133

-1,973

-2,425

0

0

0

Redeemable warrants valuation adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

Equity-based compensation

-

-

-

-

-

-

-

-

-

-

-

273

410

410

377

308

175

181

214

239

296

326

344

355

343

376

453

485

441

356

224

288

386

377

0

0

0

Realized (gain) loss on sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-57

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of building

-

-

-

-

-

223

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of finance and debt issuance costs

434

288

358

166

158

263

232

205

177

37

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in assets and liabilities:
Accounts and other receivables

721

-274

34

41

83

1,070

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,326

1,326

1,009

480

0

0

0

0

-

-

-

-

579

-290

142

211

110

0

0

0

Prepaid expenses and other current assets

-71

-29

-28

-213

-141

251

-74

113

70

13

67

229

274

-26

281

40

-69

-64

43

92

99

41

-97

-113

40

36

0

0

0

-

-

-

-

-

-

-

-

Lease liability

40

37

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-

-

-

-

-

-

-

-

-

24

42

98

41

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-200

154

57

-42

247

0

0

0

Accounts payable

-601

-207

-87

78

8

166

669

607

708

566

50

-419

-405

-326

-495

-207

-250

-196

-1,986

-918

-617

-869

794

647

-275

-617

-262

-422

-273

860

1,030

820

1,180

424

0

0

0

Accrued interest expense

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

-926

-731

444

-366

-496

-922

-1,075

-461

95

604

468

-1,159

12

329

-398

1,541

208

-1,114

37

-1,162

-251

1,105

-41

854

471

-2,167

186

637

69

1,751

822

401

458

201

0

0

0

Net cash used in operating activities

-10,670

-9,067

-9,197

-9,629

-9,555

-10,640

-8,981

-7,885

-7,490

-7,941

-9,283

-10,389

-9,330

-7,380

0

0

0

-

-

-

-

-13,964

0

0

0

-

-18,601

-17,287

-17,322

-13,136

-11,203

-10,772

-9,943

-10,096

0

0

0

Cash flows from investing activities:
Proceeds from sale of marketable securities

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits on capital leases refunded

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits on capital leases refunded

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6

-6

-7

-6

4

0

0

0

Proceeds from sale of marketable securities

-

-

-

-

-

-

-

-

-

2,799

1,698

2,952

3,870

3,370

0

0

0

-

-

-

-

-

-

-

-

-

23,348

24,921

24,999

22,658

23,128

20,506

19,563

20,896

0

0

0

Purchase of marketable securities

15,141

5,782

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

0

0

-

-

-

-

10,201

0

0

0

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of property and equipment

61

68

0

0

0

-

-

-

-

20

20

3

163

160

174

160

193

240

344

478

486

504

537

630

719

898

1,681

3,081

4,447

5,755

5,774

4,629

3,318

1,802

0

0

0

Proceeds from sale of building

-

-

-

-

-

1,050

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease deposit refund

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of patent and trademark rights

470

297

211

203

186

76

80

92

52

49

48

101

243

294

344

288

167

250

259

307

328

258

245

240

271

242

282

305

257

211

255

211

87

234

0

0

0

Net cash provided by (used in) investing activities

-1,556

-6,147

-2,376

-1,527

-2,042

92

2,697

2,240

3,280

2,730

1,616

2,846

3,462

2,916

0

0

0

-

-

-

-

2,532

0

0

0

-

2,064

-9,245

-12,470

-16,067

-3,478

6,592

9,139

8,655

0

0

0

Cash flows from financing activities:
Proceeds from lease financing obligation

-

-

-

-

-

4,080

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance and debt issuance costs

-

-

-

-

-

439

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing obligation payments

342

340

337

336

329

264

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payoff of mortgage note payable

-

-

-

-

-

-1,957

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Security deposits paid

-

-

-

-

-

114

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on capital leases

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

48

51

47

47

56

65

70

71

0

0

0

Proceeds from sale of stock, net of issuance costs

36,342

15,303

15,473

5,995

7,478

5,070

5,141

5,066

3,868

2,417

2,230

6,696

5,617

4,744

4,695

551

4,441

9,681

12,734

13,652

11,674

12,817

10,012

8,707

6,634

249

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on capital leases

-

-

-

-

-

-

-

-

-

-

-

-

-

1

3

7

15

21

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from (payments on) Margin Account Loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,356

0

0

0

-

-

-

-

Net cash provided by financing activities

37,422

16,385

17,134

8,547

10,034

9,435

9,836

7,991

7,391

4,215

3,697

7,227

5,631

4,757

0

0

0

-

-

-

-

12,785

0

0

0

-

14,977

25,668

27,730

28,312

13,817

4,270

2,207

1,624

0

0

0

Net increase in cash and cash equivalents

25,196

1,171

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase in cash and cash equivalents

-

-

-

-

-

-

-

-

3,181

-996

-3,970

-316

-237

293

3,312

-304

-1,929

-41

-101

-775

-1,163

1,353

-336

1,311

2,517

-1,409

-1,560

-864

-2,062

-891

-864

90

1,403

183

0

0

0

Supplemental disclosures of non-cash investing and financing cash flow information:
Unrealized loss on marketable securities

0

-

-

-

-

-

-4

-33

-8

16

20

-63

-43

92

416

273

99

63

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

0

-12

-11

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Stock issued to settle accounts payable

0

-

-

-

-

330

481

1,072

1,071

898

747

106

67

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating Lease - Right of Use Assets

-

188

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of redeemable warrants granted

-

-

-

-

-

-

-

-

-

-

-

-

3,188

2,454

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

62

24

-48

-4

46

41

0

0

0